[HTML][HTML] Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and …
…, BS Chin, TT D'Aquin, CF De Gascun, A Derache… - PLoS …, 2015 - journals.plos.org
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
…, A Calmy, M Inghels, H Diallo, V Calvez, A Derache… - The lancet HIV, 2018 - thelancet.com
Background Universal antiretroviral therapy (ART), as per the 2015 WHO recommendations,
might reduce population HIV incidence. We investigated the effect of universal test and treat …
might reduce population HIV incidence. We investigated the effect of universal test and treat …
Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor–containing …
…, S Avila-Rios, C Iwuji, A Derache… - The Journal of …, 2021 - academic.oup.com
Background Increased access to antiretroviral therapy (ART) has resulted in rising levels of
pretreatment human immunodeficiency virus drug resistance (PDR). This is the first …
pretreatment human immunodeficiency virus drug resistance (PDR). This is the first …
[HTML][HTML] HIV drug resistance mutations in proviral DNA from a community treatment program
A Derache, HS Shin, M Balamane, E White… - PLoS …, 2015 - journals.plos.org
Background Drug resistance mutations archived in resting memory CD4+ cells may persist
despite suppression of HIV RNA to <50 copies/ml. We sequenced pol gene from proviral …
despite suppression of HIV RNA to <50 copies/ml. We sequenced pol gene from proviral …
[HTML][HTML] T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
HIV cerebrospinal fluid (CSF) escape, where HIV is suppressed in blood but detectable in
CSF, occurs when HIV persists in the CNS despite antiretroviral therapy (ART). To determine …
CSF, occurs when HIV persists in the CNS despite antiretroviral therapy (ART). To determine …
Impact of next-generation sequencing defined human immunodeficiency virus pretreatment drug resistance on virological outcomes in the ANRS 12249 treatment-as …
A Derache, CC Iwuji, K Baisley… - Clinical Infectious …, 2019 - academic.oup.com
Background Previous studies in human immunodeficiency virus (HIV)-positive individuals
on thymidine analogue backbone antiretroviral therapy (ART) with either nevirapine or …
on thymidine analogue backbone antiretroviral therapy (ART) with either nevirapine or …
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali
D Germanaud, A Derache, M Traore… - Journal of …, 2010 - academic.oup.com
Objectives To evaluate the virological response and to describe the resistance profiles in the
case of failure after 6 months of first-line highly active antiretroviral therapy (HAART) in HIV-…
case of failure after 6 months of first-line highly active antiretroviral therapy (HAART) in HIV-…
Virological outcomes of second-line protease inhibitor–based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a …
D Collier, C Iwuji, A Derache… - Clinical infectious …, 2017 - academic.oup.com
Background. Second-line antiretroviral therapy (ART) based on ritonavir-boosted protease
inhibitors (bPIs) represents the only available option after first-line failure for the majority of …
inhibitors (bPIs) represents the only available option after first-line failure for the majority of …
[HTML][HTML] Protocol: Leveraging a demographic and health surveillance system for Covid-19 Surveillance in rural KwaZulu-Natal
MJ Siedner, G Harling, A Derache, T Smit… - Wellcome Open …, 2020 - ncbi.nlm.nih.gov
A coordinated system of disease surveillance will be critical to effectively control the coronavirus
disease 2019 (Covid-19) pandemic. Such systems enable rapid detection and mapping …
disease 2019 (Covid-19) pandemic. Such systems enable rapid detection and mapping …
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes
AI Maïga, I Malet, C Soulie, A Derache, V Koita… - 2009 - journals.sagepub.com
Background HIV type-1 (HIV-1) integrase (IN) inhibitor resistance is the consequence of
mutations that are selected in the viral IN gene targeted by antiretroviral drugs, such as …
mutations that are selected in the viral IN gene targeted by antiretroviral drugs, such as …